sciencelife.uchospitals.edu
Early trial of new drug shows promise for patients with triple-negative breast cancer
Early results of a clinical trial by Dr. Rita Nanda show that nearly 20% of patients with triple-negative breast cancer–which currently has no targeted treatments–respond to a drug call…